Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame?

Cancer Letters

Volumn 341, Issue 1, 2013, Pages 97-104

  Fessler, Evelyn ^a   Dijkgraaf, Feline E ^a   De Sousa E Melo, Felipe ^a   Medema, Jan Paul ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer stem cells; Metastasis; Microenvironment; Wnt

Indexed keywords

WNT PROTEIN;

CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER STEM CELL; CANCER THERAPY; CAUSE OF DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL RENEWAL; HUMAN; METASTASIS; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; STROMA CELL; TREATMENT FAILURE; TUMOR MICROENVIRONMENT;

EID: 84887155324     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.10.015     Document Type: Review

References (92)

1. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Reviews Cancer 2003, 3:1-6.
2. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-1909.
3. Heppner G.H. Tumor heterogeneity. Cancer Research 1984, 44:2259-2265.
4. Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research 1961, 14:213-222.
5. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 1988, 241:58-62.
6. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
7. Vermeulen L., Sprick M.R., Kemper K., Stassi G., Medema J.P. Cancer stem cells - old concepts, new insights. Cell Death and Differentiation 2008, 15:947-958.
8. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 2008, 8:755-768.
9. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 2003, 100:3983-3988.
10. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Research 2003, 63:5821-5828.
11. Vries R.G.J., Huch M., Clevers H. Stem cells and cancer of the stomach and intestine. Molecular Oncology 2010, 4:373-384.
12. Medema J.P., Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011, 474:318-326.
13. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
14. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
15. Todaro M., Perez Alea M., Di Stefano A.B., Cammareri P., Vermeulen L., Iovino F., Tripodo C., Russo A., Gulotta G., Medema J.P., Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402.
16. Vermeulen L., Todaro M., de Sousa Mello F., Sprick M.R., Kemper K., Perez Alea M., Richel D.J., Stassi G., Medema J.P. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proceedings of the National Academy of Sciences 2008, 105:13427-13432.
17. Kemper K., Sprick M.R., de Bree M., Scopelliti A., Vermeulen L., Hoek M., Zeilstra J., Pals S.T., Mehmet H., Stassi G., Medema J.P. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Research 2010, 70:719-729.
18. Shmelkov S.V., Butler J.M., Hooper A.T., Hormigo A., Kushner J., Milde T., Clair R.S., Baljevic M., White I., Jin D.K., Chadburn A., Murphy A.J., Valenzuela D.M., Gale N.W., Thurston G., Yancopoulos G.D., Angelica M.D., Kemeny N., Lyden D., Rafii S. CD133 expression is not restricted to stem cells, and both CD113+ and CD133- metastatic colon cancer cells initiate tumors. The Journal of Clinical Investigation 2008, 118:2111-2120.
19. Chu P., Clanton D.J., Snipas T.S., Lee J., Mitchell E., Nguyen M.-L., Hare E., Peach R.J. Characterization of a subpopulation of colon cancer cells with stem cell-like properties. International Journal of Cancer 2009, 124:1312-1321.
20. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H.M., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Research 2006, 66:9339-9344.
21. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
22. Boiko A.D., Razorenova O.V., van de Rijn M., Swetter S.M., Johnson D.L., Ly D.P., Butler P.D., Yang G.P., Joshua B., Kaplan M.J., Longaker M.T., Weissman I.L. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010, 466:133-137.
23. Loeffler M., Roeder I. Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models - a conceptual approach. Cells, Tissues, Organs 2002, 171:8-26.
24. Vermeulen L., De Sousa E Melo F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., Sprick M.R., Kemper K., Richel D.J., Stassi G., Medema J.P. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biology 2010, 12:468-476.
25. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics 1998, 19:379-383.
26. Barker N., van Es J.H., Kuipers J., Kujala P., Van Den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
27. Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W., Huelsken J. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 2008, 452:650-653.
28. He X.C., Zhang J., Tong W.-G., Tawfik O., Ross J., Scoville D.H., Tian Q., Zeng X., He X., Wiedemann L.M., Mishina Y., Li L. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nature Genetics 2004, 36:1117-1121.
29. Auclair B.A., Benoit Y.D., Rivard N., Mishina Y., Perreault N. Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology 2007, 133:887-896.
30. Hardwick J.C.H., Van Den Brink G.R., Bleuming S.A., Ballester I., Van Den Brande J.M.H., Keller J.J., Offerhaus G.J.A., Van Deventer S.J.H., Peppelenbosch M.P. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 2004, 126:111-121.
31. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
32. Hardwick J.C., Kodach L.L., Offerhaus G.J., Van Den Brink G.R. Bone morphogenetic protein signalling in colorectal cancer. Nature Reviews Cancer 2008, 8:806-811.
33. Lombardo Y., Scopelliti A., Cammareri P., Todaro M., Iovino F., Ricci-Vitiani L., Gulotta G., Dieli F., de Maria R., Stassi G. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011, 140:297-309.
34. Postovit L.-M., Margaryan N.V., Seftor E.A., Kirschmann D.A., Lipavsky A., Wheaton W.W., Abbott D.E., Seftor R.E.B., Hendrix M.J.C. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proceedings of the National Academy of Sciences 2008, 105:4329-4334.
35. Lonardo E., Hermann P.C., Mueller M.-T., Huber S., Balic A., Miranda-Lorenzo I., Zagorac S., Alcala S., Rodriguez-Arabaolaza I., Ramirez J.C., Torres-Ruíz R., Garcia E., Hidalgo M., Cebrián D.Á., Heuchel R., Löhr M., Berger F., Bartenstein P., Aicher A., Heeschen C. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 2011, 9:433-446.
36. van Es J.H., van Gijn M.E., Riccio O., Van Den Born M., Vooijs M., Begthel H., Cozijnsen M., Robine S., Winton D.J., Radtke F., Clevers H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963.
37. Hoey T., Yen W.-C., Axelrod F., Basi J., Donigian L., Dylla S., Fitch-Bruhns M., Lazetic S., Park I.-K., Sato A., Satyal S., Wang X., Clarke M.F., Lewicki J., Gurney A. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009, 5:168-177.
38. Gaiano N., Fishell G. The role of notch in promoting glial and neural stem cell fates. Annual Review of Neuroscience 2002, 25:471-490.
39. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K., Temple S. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004, 304:1338-1340.
40. Fan X., Khaki L., Zhu T.S., Soules M.E., Talsma C.E., Gul N., Koh C., Zhang J., Li Y.-M., Maciaczyk J., Nikkhah G., Dimeco F., Piccirillo S., Vescovi A.L., Eberhart C.G. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010, 28:5-16.
41. Egeblad M., Nakasone E.S., Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Developmental Cell 2010, 18:884-901.
42. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
43. Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G., Van Den Born M., Barker N., Shroyer N.F., van de Wetering M., Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469:415-418.
44. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
45. Borovski T., Verhoeff J.J.C., ten Cate R., Cameron K., de Vries N.A., van Tellingen O., Richel D.J., van Furth W.R., Medema J.P., Sprick M.R. Tumor microvasculature supports proliferation and expansion of glioma-propagating cells. International Journal of Cancer 2009, 125:1222-1230.
46. Louissaint A., Rao S., Leventhal C., Goldman S.A. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 2002, 34:945-960.
47. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82.
48. Ramírez-Castillejo C., Sánchez-Sánchez F., Andreu-Agulló C., Ferrón S.R., Aroca-Aguilar J.D., Sánchez P., Mira H., Escribano J., Fariñas I. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nature Neuroscience 2006, 9:331-339.
49. Charles N., Ozawa T., Squatrito M., Bleau A.-M., Brennan C.W., Hambardzumyan D., Holland E.C. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 2010, 6:141-152.
50. Zhu T.S., Costello M.A., Talsma C.E., Flack C.G., Crowley J.G., Hamm L.L., He X., Hervey-J Umper S.L., Heth J.A., Muraszko K.M., Dimeco F., Vescovi A.L., Fan X. Endothelial cells create a stem cell niche in glioblastoma by providing Notch ligands that nurture self-renewal of cancer stem-like cells. Cancer Research 2011, 71:6061-6072.
51. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
52. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
53. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
54. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
55. Li Y., Li A., Glas M., Lal B., Ying M., Sang Y., Xia S., Trageser D., Guerrero-Cázares H., Eberhart C.G., Quiñones-Hinojosa A., Scheffler B., Laterra J. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proceedings of the National Academy of Sciences 2011, 108:9951-9956.
56. Mani S.A., Guo W., Liao M.-J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
57. Roesch A., Fukunaga-Kalabis M., Schmidt E.C., Zabierowski S.E., Brafford P.A., Vultur A., Basu D., Gimotty P., Vogt T., Herlyn M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141:583-594.
58. Shackleton M., Quintana E., Fearon E.R., Morrison S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-829.
59. Quintana E., Shackleton M., Foster H.R., Fullen D.R., Sabel M.S., Johnson T.M., Morrison S.J. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010, 18:510-523.
60. Gupta Piyush B., Fillmore Christine M., Jiang G., Shapira Sagi D., Tao K., Kuperwasser C., Lander Eric S. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 146:633-644.
61. Voog J., D'Alterio C., Jones D.L. Multipotent somatic stem cells contribute to the stem cell niche in the Drosophila testis. Nature 2008, 454:1132-1136.
62. Borovski T., De Sousa E Melo F., Vermeulen L., Medema J.P. Cancer stem cell niche: the place to be. Cancer Research 2011, 71:634-639.
63. Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K.E., Geber A., Fligelman B., Leversha M., Brennan C., Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468:829-833.
64. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E.A., Stassi G., Larocca L.M., De Maria R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
65. Takaku K., Oshima M., Miyoshi H., Matsui M., Seldin M.F., Taketo M.M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998, 92:645-656.
66. Kitamura T., Kometani K., Hashida H., Matsunaga A., Miyoshi H., Hosogi H., Aoki M., Oshima M., Hattori M., Takabayashi A., Minato N., Taketo M.M. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nature Genetics 2007, 39:467-475.
67. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nature Reviews Cancer 2009, 9:239-252.
68. Labelle M., Begum S., Hynes R.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20:576-590.
69. Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Reviews 1889, 8(1989):98-101.
70. Ewing J. Neoplastic Diseases: A Treatise on Tumors 1928, WB Saunders, Philadelphia, PA. third ed.
71. Fidler I.J., Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977, 197:893-895.
72. Hart I.R., Fidler I.J. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Research 1980, 40:2281-2287.
73. Grange C., Tapparo M., Collino F., Vitillo L., Damasco C., Deregibus M.C., Tetta C., Bussolati B., Camussi G. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung pre-metastatic niche. Cancer Research 2011, 71:5346-5356.
74. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
75. Peinado H., Alečković M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., Hergueta-Redondo M., Williams C., García-Santos G., Ghajar C.M., Nitadori-Hoshino A., Hoffman C., Badal K., Garcia B.a., Callahan M.K., Yuan J., Martins V.R., Skog J., Kaplan R.N., Brady M.S., Wolchok J.D., Chapman P.B., Kang Y., Bromberg J., Lyden D. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine 2012, 18:883-891.
76. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
77. Balic M., Lin H., Young L., Hawes D., Giuliano A., McNamara G., Datar R.H., Cote R.J. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clinical Cancer Research 2006, 12:5615-5621.
78. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., Smith M.R., Kwak E.L., Digumarthy S., Muzikansky A., Ryan P., Balis U.J., Tompkins R.G., Haber D.A., Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
79. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
80. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nature Reviews Cancer 2005, 5:744-749.
81. Dieter S.M., Ball C.R., Hoffmann C.M., Nowrouzi A., Herbst F., Zavidij O., Abel U., Arens A., Weichert W., Brand K., Koch M., Weitz J., Schmidt M., von Kalle C., Glimm H. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 2011, 9:357-365.
82. Charafe-Jauffret E., Ginestier C., Iovino F., Tarpin C., Diebel M., Esterni B., Houvenaeghel G., Extra J.-M., Bertucci F., Jacquemier J., Xerri L., Dontu G., Stassi G., Xiao Y., Barsky S.H., Birnbaum D., Viens P., Wicha M.S. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clinical Cancer Research 2010, 16:45-55.
83. Liu R., Wang X., Chen G.Y., Dalerba P., Gurney A., Hoey T., Sherlock G., Lewicki J., Shedden K., Clarke M.F. The prognostic role of a gene signature from tumorigenic breast-cancer cells. The New England Journal of Medicine 2007, 356:217-226.
84. Liu H., Patel M.R., Prescher J.A., Patsialou A., Qian D., Lin J., Wen S., Chang Y.-F., Bachmann M.H., Shimono Y., Dalerba P., Adorno M., Lobo N., Bueno J., Dirbas F.M., Goswami S., Somlo G., Condeelis J., Contag C.H., Gambhir S.S., Clarke M.F. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proceedings of the National Academy of Sciences 2010, 107:18115-18120.
85. Malanchi I., Santamaria-Martínez A., Susanto E., Peng H., Lehr H.-A., Delaloye J.-F., Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2011, 481:85-89.
86. Oskarsson T., Acharyya S., Zhang X.H.-F., Vanharanta S., Tavazoie S.F., Morris P.G., Downey R.J., Manova-Todorova K., Brogi E., Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nature Medicine 2011, 17:867-874.
87. Pallini R., Ricci-Vitiani L., Banna G.L., Signore M., Lombardi D., Todaro M., Stassi G., Martini M., Maira G., Larocca L.M., De Maria R. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clinical Cancer Research 2008, 14:8205-8212.
88. Merlos-Suárez A., Barriga F.M., Jung P., Iglesias M., Céspedes M.V., Rossell D., Sevillano M., Hernando-Momblona X., da Silva-Diz V., Muñoz P., Clevers H., Sancho E., Mangues R., Batlle E. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011, 8:511-524.
89. Gerger A., Zhang W., Yang D., Bohanes P., Ning Y., Winder T., LaBonte M.J., Wilson P.M., Benhaim L., Paez D., El-Khoueiry R., El-Khoueiry A., Kahn M., Lenz H.-J. Common cancer stem cell gene variants predict colon cancer recurrence. Clinical Cancer Research 2011, 17:6934-6943.
90. Eppert K., Takenaka K., Lechman E.R., Waldron L., Nilsson B., van Galen P., Metzeler K.H., Poeppl A., Ling V., Beyene J., Canty A.J., Danska J.S., Bohlander S.K., Buske C., Minden M.D., Golub T.R., Jurisica I., Ebert B.L., Dick J.E. Stem cell gene expression programs influence clinical outcome in human leukemia. Nature Medicine 2011, 17:1086-1093.
91. Bos P.D., Massagué J., Nguyen D.X. Metastasis: from dissemination to organ-specific colonization. Nature Reviews Cancer 2009, 9:274-284.
92. de Sousa E Melo F., Colak S., Buikhuisen J., Koster J., Cameron K., de Jong J.H., Tuynman J.B., Prasetyanti P.R., Fessler E., Van Den Bergh S.P., Rodermond H., Dekker E., van der Loos C.M., Pals S.T., van de Vijver M.J., Versteeg R., Richel D.J., Vermeulen L., Medema J.P. Methylation of cancer-stem-cell-associated wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011, 9:476-485.